Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.4K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Seizures: Classification01:13

Seizures: Classification

1.7K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

711
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
711
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.4K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

957
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
957
Overview of Synapses01:25

Overview of Synapses

5.6K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High Theta (4-10 Hz) power as a biomarker of inhibition during epileptogenesis in an animal model of mesial temporal lobe epilepsy.

Experimental neurology·2026
Same author

Sub-Anesthetic Ketamine Administration Decreases Deviance Detection Responses at the Cellular, Population- and Mesoscale Levels.

The European journal of neuroscience·2026
Same author

Influence of the estrous cycle on seizure activity in a model of mesial temporal lobe epilepsy.

Experimental neurology·2025
Same author

Spreading depolarization and its influence on epileptiform activity.

Epilepsia·2025
Same author

Mono-allelic p.R37H Dehydrodolichyl Diphosphate Synthase variants lead to protein glycosylation defects, aberrant lipid profiles and interneuron scarcity in a novel mouse model of progressive epileptic encephalopathy.

bioRxiv : the preprint server for biology·2025
Same author

Syngap1 regulates the synaptic drive and membrane excitability of Parvalbumin-positive interneurons in mouse auditory cortex.

eLife·2025

Related Experiment Video

Updated: Feb 17, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.6K

KCC2, epileptiform synchronization, and epileptic disorders.

Graziella Di Cristo1, Patricia N Awad2, Shabnam Hamidi3

  • 1Neurosciences Department, Université de Montréal, Montréal, Québec H3T 1N8, Canada; CHU Sainte-Justine Research Center, Montréal, Québec H3T 1C5, Canada.

Progress in Neurobiology
|December 4, 2017
PubMed
Summary
This summary is machine-generated.

The K+−Cl− co-transporter 2 (KCC2) extrudes chloride from neurons, crucial for inhibitory neurotransmission. Altered KCC2 function is linked to epilepsy, suggesting it as a therapeutic target.

Keywords:
Context-specificEpilepsyGABAJuvenileKCC2Pathology-specificSeizures

More Related Videos

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

27.1K
Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue
13:14

Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue

Published on: October 26, 2014

21.3K

Related Experiment Videos

Last Updated: Feb 17, 2026

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
10:08

Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting

Published on: December 9, 2022

2.6K
Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
11:54

Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy

Published on: January 29, 2018

27.1K
Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue
13:14

Multi-electrode Array Recordings of Human Epileptic Postoperative Cortical Tissue

Published on: October 26, 2014

21.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epilepsy Research

Background:

  • The K+−Cl− co-transporter KCC2 is essential for neuronal chloride extrusion.
  • Maintaining low intracellular chloride via KCC2 is critical for hyperpolarizing GABAergic neurotransmission.
  • Dysregulation of KCC2 is implicated in epilepsy.

Purpose of the Study:

  • To review the role of KCC2 in epileptiform synchronization.
  • To examine alterations in KCC2 expression and function in chronic epilepsy.
  • To explore KCC2 modulation as a therapeutic strategy for epilepsy.

Main Methods:

  • Literature review of KCC2 function in neuronal excitability.
  • Analysis of studies on KCC2 in epilepsy models and human epilepsy.
  • Investigation of molecular mechanisms affecting KCC2 activity post-seizure.

Main Results:

  • KCC2 activity is vital for inhibitory GABAergic signaling.
  • Reduced KCC2 function can lead to depolarizing GABAergic transmission.
  • Evidence links altered KCC2 expression/function to epilepsy in developing and adult brains.

Conclusions:

  • KCC2 plays a significant role in regulating neuronal inhibition and epilepsy.
  • Changes in KCC2 activity following seizures are mechanistically linked to epilepsy.
  • Modulating KCC2 function represents a promising therapeutic avenue for epilepsy treatment.